Karin A. Pacheco

Karin A. Pacheco

Auto-generated profile, based on publicly available information

Karin A. Pacheco

Department of Medicine, National Jewish Health, Denver, CO 80206, USA

Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 September 2018 in Clinical Reviews in Allergy & Immunology
Verified
Journal Article
Closed access
PDF file
KPKarin A. Pacheco
Karin A. Pacheco

1 September 2015 in The Journal of Allergy and Clinical Immunology: In Practice
Verified
Journal Article
Closed access
KPKarin A. Pacheco
Karin A. Pacheco

28 October 2021 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
RMRichard Thomas Meehan
Richard Thomas Meehan
ERElizabeth A. Regan
Elizabeth A. Regan
EHEric D. Hoffman
Eric D. Hoffman
MWMolly L. Wolf
Molly L. Wolf
MGMary T. Gill
Mary T. Gill
VKVijaya Knight
Vijaya Knight
Background: There are currently no effective disease-modifying drugs to prevent cartilage loss in osteoarthritis and synovial fluid is a potentially valuable source of biomarkers to understand the pathogenesis of different types of arthritis and identify drug responsiveness. The aim of this study was to compare the differences between SF cytokines and other proteins in patients with OA (n = 21) to those with RA (n = 27) and normal knees (n = 3). Methods: SF was obtained using ultrasound (US) guidance and an external pneumatic compression device. RA patients were categorized as active (n = 20) or controlled (n = 7) based upon SF white blood cell counts (> or <300 cells/mm3). Samples were cryopreserved and analyzed by multiplex fluorescent bead assays (Luminex). Between-group differences of 16 separate biomarker proteins were identified using ANOVA on log10-transformed concentrations with p values adjusted for multiple testing. Results: Only six biomarkers were significantly higher in SF from active RA compared to OA—TNF-α, IL-1-β IL-7, MMP-1, MMP-2, and MMP-3. Only MMP-8 levels in RA patients correlated with SF WBC counts (p < 0.0001). Among OA patients, simultaneous SF IL-4, IL-6, IL-8, and IL-15 levels were higher than serum levels, whereas MMP-8, MMP-9, and IL-18 levels were higher in serum (p < 0.05). Conclusion: These results support the growing evidence that OA patients have a pro-inflammatory/catabolic SF environment. SF biomarker analysis using multiplex testing and US guidance may distinguish OA phenotypes and identify treatment options based upon targeted inflammatory pathways similar to patients with RA.

1 April 2003 in American Journal of Respiratory and Critical Care Medicine
Verified
Journal Article
Closed access
KPKarin A. Pacheco
Karin A. Pacheco
CMCharles McCammon
Charles McCammon
ALAndrew H. Liu
Andrew H. Liu
PTPeter S Thorne
Peter S Thorne
MOMarsha E. O'NEill
Marsha E. O'NEill
CRCecile S. Rose
Cecile S. Rose
Research scientists, laboratory technicians, and animal handlers who work with animals frequently report respiratory and skin symptoms from exposure to laboratory animals (LA). However, on the basis of prick skin tests or RASTs, only half are sensitized to LA. We hypothesized that aerosolized endotoxin from mouse work is responsible for symptoms in nonsensitized workers. We performed a cross-sectional study of 269/310 (87%) workers at a research institution. Subjects completed a questionnaire and underwent prick skin tests (n = 254) or RASTs (n = 16) for environmental and LA allergens. We measured airborne mouse allergen and endotoxin in the animal facility and in research laboratories. Of 212 workers not sensitized to mice, 34 (16%) reported symptoms compared with 26 (46%) of mouse-sensitized workers (p < 0.001). Symptomatic workers were more likely to be atopic, regardless of mouse sensitization status. Symptomatic non–mouse-sensitized workers spent more time performing animal experiments in the animal facility (p = 0.0001) and in their own laboratories (p < 0.0001) and had higher daily endotoxin exposure (p = 0.008) compared with asymptomatic coworkers. In a multivariate model, daily endotoxin exposure most strongly predicted symptoms to mice in non–mouse-sensitized workers (odds ratio = 30.8, p = 0.003). We conclude that airborne endotoxin is associated with respiratory symptoms to mice in non–mouse-sensitized scientists and technicians.

1 December 2001 in Clinical and Experimental Immunology
Verified
Journal Article
Closed access
PDF file
KPK A Pacheco
K A Pacheco
MTMaciej Stanislaw Tarkowski
Maciej Stanislaw Tarkowski
CSC. Sterritt
C. Sterritt
JNJ. Negri
J. Negri
LRL. J. Rosenwasser
L. J. Rosenwasser
LBL. Borish
L. Borish

5 May 2006 in Annals of Occupational Hygiene
Verified
Journal Article
Open access
PDF file
KPKarin A. Pacheco
Karin A. Pacheco
CMCHARLES McCAMMON
CHARLES McCAMMON
PTPeter S Thorne
Peter S Thorne
MOMarsha E. O'Neill
Marsha E. O'Neill
ALAndrew H. Liu
Andrew H. Liu
CRCecile S. Rose
Cecile S. Rose
Objectives: Researchers and technicians who use mice in research are exposed to complex mixtures containing mouse allergen, endotoxin and particulates from animals, bedding and feed. The particle characteristics of these different exposures, and whether they are encountered together or separately, are important to better understand their adjuvant and allergic effects. Endotoxin and mouse allergen are derived from the same animal source, but have different physicochemical attributes. It is not known if airborne exposures to these agents are correlated in the laboratory animal workplace. Methods: Side-by-side personal and area samples for airborne endotoxin (52), mouse allergen (46) and total particulates (43) were obtained in the animal facility and laboratories of a medical research institution. Animal handlers and researchers reported time spent on work tasks with mice, symptoms upon exposure to mice and mouse sensitization was determined by skin test or RAST. Results: Mean airborne endotoxin exposure was highest during mouse experiments in the animal facility at 960 pg m−3, peaked at 3125 pg m−3, and ranged from 46 to 678 pg m−3 with work in mouse rooms and research labs. Mouse allergen concentrations were highest during direct mouse work and background in research labs (mean 63–68 ng m−3, range 41–271 ng m−3), but were undetectable during mouse research performed under a hood. Endotoxin and mouse allergen concentrations were correlated during direct research with mice and mouse care activities. Particle counts were low, typically <1 cm−3, varied widely, and exhibited peaks and valleys during different work tasks. From 80–90% of particles were <1 μm in aerodynamic diameter during background measurements. The contribution of respirable particles 1–5 μm in size increased to 25–30% during mouse care and mouse research activities, but we found no association between any particle size and endotoxin or mouse allergen concentrations. Animal handlers and researchers in the mouse facility were exposed to the highest daily endotoxin concentrations, whereas researchers working with mice in the mouse facility and in laboratories were exposed to the highest daily mouse allergen concentrations. Conclusions: These findings suggest that endotoxin and mouse allergen are co-exposures during mouse handling and research, and that control of exposure peaks may be necessary to limit allergic disease in the laboratory animal workplace.